Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk SARS-CoV-2 infection (COVID-19)
Peter A. McCullough, Paul Alexander, Robin Armstrong, et al.
Reviews in Cardiovascular Medicine (2020) Vol. 21, Iss. 4
Open Access | Times Cited: 80

Showing 1-25 of 80 citing articles:

The Drug Repurposing for COVID-19 Clinical Trials Provide Very Effective Therapeutic Combinations: Lessons Learned From Major Clinical Studies
Chiranjib Chakraborty, Ashish Ranjan Sharma, Manojit Bhattacharya, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 138
Doxycycline for community treatment of suspected COVID-19 in people at high risk of adverse outcomes in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial
Christopher Butler, Ly‐Mee Yu, Jienchi Dorward, et al.
The Lancet Respiratory Medicine (2021) Vol. 9, Iss. 9, pp. 1010-1020
Open Access | Times Cited: 67
A randomized double-blind placebo-controlled clinical trial of nitazoxanide for treatment of mild or moderate COVID-19
Jean‐François Rossignol, Matthew Bardin, Jessica Fulgencio, et al.
EClinicalMedicine (2022) Vol. 45, pp. 101310-101310
Open Access | Times Cited: 40
Determinants of COVID-19 vaccine-induced myocarditis
Jessica Rose, Nicolas Hulscher, Peter A. McCullough
Therapeutic Advances in Drug Safety (2024) Vol. 15
Open Access | Times Cited: 12
COVID-19 in People With Schizophrenia: Potential Mechanisms Linking Schizophrenia to Poor Prognosis
Mohapradeep Mohan, Benjamin I. Perry, Ponnusamy Saravanan, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 35
Effectiveness of Ivermectin-Based Multidrug Therapy in Severely Hypoxic, Ambulatory COVID-19 Patients
Sabine Hazan, Sonya Davé, Anoja W. Gunaratne, et al.
Future Microbiology (2022) Vol. 17, Iss. 5, pp. 339-350
Open Access | Times Cited: 26
Preclinical and Clinical Investigations of Potential Drugs and Vaccines for COVID-19 Therapy: A Comprehensive Review With Recent Update
Md. Easin Mia, Mithu Howlader, Farzana Akter, et al.
Clinical Pathology (2024) Vol. 17
Open Access | Times Cited: 5
Early combination therapy with hydroxychloroquine and azithromycin reduces mortality in 10,429 COVID-19 outpatients
Matthieu Million, Jean‐Christophe Lagier, Hervé Tissot‐Dupont, et al.
Reviews in Cardiovascular Medicine (2021) Vol. 22, Iss. 3, pp. 1063-1063
Open Access | Times Cited: 32
Deep Learning–Based COVID-19 Pneumonia Classification Using Chest CT Images: Model Generalizability
Dan Nguyen, Fernando Uliana Kay, Jun Tan, et al.
Frontiers in Artificial Intelligence (2021) Vol. 4
Open Access | Times Cited: 30
SARS–CoV-2 Immuno-Pathogenesis and Potential for Diverse Vaccines and Therapies: Opportunities and Challenges
Andrew R. McGill, Roukiah Khalil, Rinku Dutta, et al.
Infectious Disease Reports (2021) Vol. 13, Iss. 1, pp. 102-125
Open Access | Times Cited: 27
Molnupiravir combined with different repurposed drugs further inhibits SARS-CoV-2 infection in human nasal epithelium in vitro
Hulda R. Jónsdóttir, Denise Siegrist, Thomas Julien, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 150, pp. 113058-113058
Open Access | Times Cited: 22
Early multidrug treatment of SARS-CoV-2 infection (COVID-19) and reduced mortality among nursing home (or outpatient/ambulatory) residents
Paul Alexander, Robin Armstrong, George Fareed, et al.
Medical Hypotheses (2021) Vol. 153, pp. 110622-110622
Open Access | Times Cited: 25
A Novel Approach of Combining Methylene Blue Photodynamic Inactivation, Photobiomodulation and Oral Ingested Methylene Blue in COVID-19 Management: A Pilot Clinical Study with 12-Month Follow-Up
Juliette Hepburn, Susan Williams-Lockhart, René‐Jean Bensadoun, et al.
Antioxidants (2022) Vol. 11, Iss. 11, pp. 2211-2211
Open Access | Times Cited: 17
COVID-19 and cardiovascular system—a comprehensive review
Ibrahim Alshahrani, Jagadish Hosmani, Vidya Gurram Shankar, et al.
Reviews in Cardiovascular Medicine (2021) Vol. 22, Iss. 2
Open Access | Times Cited: 21
Cardio-Pulmonary-Renal Consequences of Severe COVID-19
Göksel Güven, Can İnce, Arzu Topeli̇, et al.
Cardiorenal Medicine (2021) Vol. 11, Iss. 3, pp. 133-139
Open Access | Times Cited: 20
The Impact of COVID-19 Pandemic on Dermatological Conditions: A Novel, Comprehensive Review
Gehan A. Pendlebury, Peter Oro, William Haynes, et al.
Dermatopathology (2022) Vol. 9, Iss. 3, pp. 212-243
Open Access | Times Cited: 13
WITHDRAWN: A Report on Myocarditis Adverse Events in the U.S. Vaccine Adverse Events Reporting System (VAERS) in Association with COVID-19 Injectable Biological Products
Jessica Rose, Peter A. McCullough
Current Problems in Cardiology (2021), pp. 101011-101011
Open Access | Times Cited: 16
Health insurance system and resilience to epidemics
Jimin Hong, S. Hun Seog
Risk Analysis (2022) Vol. 43, Iss. 1, pp. 97-114
Closed Access | Times Cited: 10
The Effect of Nitazoxanide on the Clinical Outcomes in Patients with COVID-19: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Mohamed Abuelazm, Ahmed Ghanem, Ahmed K. Awad, et al.
Clinical Drug Investigation (2022) Vol. 42, Iss. 12, pp. 1031-1047
Open Access | Times Cited: 10
SARS-CoV-2 infection: molecular mechanisms of severe outcomes to suggest therapeutics
Nicholas Hartog, William E. Faber, Austin Frisch, et al.
Expert Review of Proteomics (2021) Vol. 18, Iss. 2, pp. 105-118
Open Access | Times Cited: 14
High-flow oxygen therapy in elderly patients infected with SARS-CoV2 with a contraindication for transfer to an intensive care unit: A preliminary report
Jean‐Christophe Lagier, Sophie Amrane, Morgane Mailhe, et al.
International Journal of Infectious Diseases (2021) Vol. 108, pp. 1-3
Open Access | Times Cited: 13
The Effects of Vitamin C on the Multiple Pathophysiological Stages of COVID-19
Jorge R. Miranda-Massari, Alondra P. Toro, Doris Loh, et al.
Life (2021) Vol. 11, Iss. 12, pp. 1341-1341
Open Access | Times Cited: 13
Safety and tolerability of hydroxychloroquine in health care workers and first responders for the prevention of COVID-19: WHIP COVID-19 Study
John E. McKinnon, Dee Dee Wang, Marcus Zervos, et al.
International Journal of Infectious Diseases (2021) Vol. 116, pp. 167-173
Open Access | Times Cited: 13
Acute COVID-19 Management in Heart Failure Patients: A Specific Setting Requiring Detailed Inpatient and Outpatient Hospital Care
Alberto Palazzuoli, Matteo Beltrami, Peter A. McCullough
Biomedicines (2023) Vol. 11, Iss. 3, pp. 790-790
Open Access | Times Cited: 5
Country differences in transmissibility, age distribution and case-fatality of SARS-CoV-2: a global ecological analysis
Caroline Favas, Prudence Jarrett, Ruwan Ratnayake, et al.
International Journal of Infectious Diseases (2021) Vol. 114, pp. 210-218
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top